Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
As of close of business last night, Zentalis Pharmaceuticals Inc’s stock clocked out at $1.77, down -2.21% from its previous closing price of $1.81. In other words, the price has decreased by -$2.21 from its previous closing price. On the day, 0.64 million shares were traded. ZNTL stock price reached its highest trading level at $1.88 during the session, while it also had its lowest trading level at $1.76.
Ratios:
To gain a deeper understanding of ZNTL’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 7.29 and its Current Ratio is at 7.29. In the meantime, Its Debt-to-Equity ratio is 0.12 whereas as Long-Term Debt/Eq ratio is at 0.11.
On June 20, 2024, UBS Downgraded its rating to Neutral which previously was Buy and also lowered its target price recommendation from $28 to $5.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Feb 06 ’25 when Bruns Ingmar bought 20,000 shares for $2.28 per share. The transaction valued at 45,656 led to the insider holds 36,629 shares of the business.
Cam Gallagher bought 687 shares of ZNTL for $1,374 on Feb 11 ’25. On Feb 03 ’25, another insider, Vultaggio Vincent, who serves as the PAO and Interim PFO of the company, sold 2,615 shares for $1.71 each. As a result, the insider received 4,476 and left with 189,826 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ZNTL now has a Market Capitalization of 126139760 and an Enterprise Value of -221846240. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.11 while its Price-to-Book (P/B) ratio in mrq is 0.36. Its current Enterprise Value per Revenue stands at -5.47 whereas that against EBITDA is 1.067.
Stock Price History:
The Beta on a monthly basis for ZNTL is 1.72, which has changed by -0.87229437 over the last 52 weeks, in comparison to a change of 0.09506309 over the same period for the S&P500. Over the past 52 weeks, ZNTL has reached a high of $16.26, while it has fallen to a 52-week low of $1.61. The 50-Day Moving Average of the stock is -21.28%, while the 200-Day Moving Average is calculated to be -52.65%.
Shares Statistics:
It appears that ZNTL traded 1.88M shares on average per day over the past three months and 860110 shares per day over the past ten days. A total of 71.15M shares are outstanding, with a floating share count of 53.59M. Insiders hold about 24.81% of the company’s shares, while institutions hold 87.47% stake in the company. Shares short for ZNTL as of 1740700800 were 5174424 with a Short Ratio of 2.75, compared to 1738281600 on 4848542. Therefore, it implies a Short% of Shares Outstanding of 5174424 and a Short% of Float of 14.62.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
